Work

Positioning Drug Allergy Delabeling as a Critical Tool for Precision Medicine, Quality Improvement, and Public Health

Year: 2020

Type: editorial

Source: The Journal of Allergy and Clinical Immunology In Practice

DOI: 10.1016/j.jaip.2020.07.046

Authors: Kimberly G. Blumenthal, Elizabeth J. Phillips

Institutions: Harvard University, Massachusetts General Hospital, Murdoch University, Vanderbilt University Medical Center

Language: English

Topic: Drug-Induced Adverse Reactions

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: American Academy of Allergy Asthma and Immunology, Massachusetts General Hospital, National Institutes of Health, National Health and Medical Research Council, National Human Genome Research Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases

Awards: Improving Prediction of Drug Action, Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivors, Single Cell definition of pathogenic T cells in Drug-induced Stevens-Johnson-Syndrome/Toxic epidermal necrolysis, Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study), NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

OpenAlex ID: W3047982569

Cites: 10

Cited by: 8

Related to: 10